Carina Biotech
Company Details
Status: Private
Employees: 1-10
Location:
Mawson Lakes, South Australia
Type:
sample
Technology:
sample
sample
sample
sample
sample
About: Carina Biotech
An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing.
We are working to…
1. Expand the clinical indications for T cell therapies
2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable
Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Carina Biotech | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.